This journal focuses on the development and investigation of therapeutic agents and strategies for a range of diseases. It covers research on natural products, synthetic compounds, and nanotechnological approaches for drug delivery. The scope includes studies on cancer, metabolic disorders like diabetes and nonalcoholic fatty liver disease, neurodegenerative diseases such as Alzheimer's, and infectious diseases. Methodologies often involve network pharmacology, bioinformatics, molecular docking, and in vitro/in vivo experimental validation.
Computational Drug Discovery MethodsCancer Mechanisms and TherapyInflammatory Bowel DiseaseDiverse Scientific and Economic StudiesNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery14-3-3 protein interactionsCholinesterase and Neurodegenerative DiseasesMicroRNA in disease regulationReceptor Mechanisms and Signaling